Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The G6PC mRNA 3'-untranslated region (3'-UTR) is a non-coding regulatory segment of the messenger RNA that encodes the glucose-6-phosphatase catalytic subunit, the enzyme responsible for the final step of both gluconeogenesis and glycogenolysis in the liver and kidneys. This region serves as a scaffold for various regulatory elements, including AU-rich elements (AREs) and binding sites for microRNAs such as miR-494 and miR-122, which collectively dictate the stability and translational efficiency of the G6PC transcript. In metabolic disorders like Type 2 diabetes, G6PC is frequently overexpressed, contributing to excessive hepatic glucose output and hyperglycemia; consequently, the 3'-UTR is a primary target for antisense oligonucleotides (ASOs) and RNA interference (RNAi) therapies designed to trigger mRNA degradation and lower blood sugar. Conversely, genetic polymorphisms within this region, such as rs2229611, can impair mRNA stability and are associated with an increased risk or severity of Glycogen Storage Disease type Ia (GSD-Ia). Therapeutic strategies targeting this region aim to modulate glucose production by either silencing the endogenous transcript in overactive states or optimizing the stability of synthetic mRNA for replacement therapies in deficiency states.
Antisense inhibition, RNase H-mediated mRNA degradation, microRNA-mediated translational repression, and RNA interference (RNAi).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucose-6-phosphatase catalytic subunit mRNA 3'-untranslated region (G6PC mRNA 3'-UTR).